Below are the most recent publications written about "Adrenergic beta-2 Receptor Agonists" by people in Profiles.
-
Levy ML, Kocks JWH, Bosnic-Anticevich S, Safioti G, Reich M, Depietro M, Castro M, Farooqui N, Lugogo NL, Brown R, Hill T, Li T, Chrystyn H. Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler. NPJ Prim Care Respir Med. 2024 08 20; 34(1):23.
-
Pace WD, Brandt E, Carter VA, Chang KL, Edwards CL, Evans A, Fox C, Gaona G, Han MK, Kaplan AG, Kent R, Kocks JWH, Kruszyk M, Le Lievre CE, Li Voti T, Mahle C, Make B, Ratigan AR, Shaikh A, Skolnik N, Stanley B, Yawn BP, Price DB. COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry. Ann Fam Med. 2022 Jul-Aug; 20(4):319-327.
-
Skolnik NS, Nguyen TS, Shrestha A, Ray R, Corbridge TC, Brunton SA. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting ?2-agonist bronchodilators. Postgrad Med. 2020 Mar; 132(2):198-205.
-
Strange C, Walker V, DePietro M, Tong J, Kurlander J, Carlyle M, Millette LA, Wittbrodt E. Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:1377-1388.
-
Bengtson LGS, DePietro M, McPheeters J, Fox KM. Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy. Ther Adv Respir Dis. 2018 Jan-Dec; 12:1753466618772750.
-
Gray MP, Keeney GE, Grahl MJ, Gorelick MH, Spahr CD. Improving Guideline-Based Care of Acute Asthma in a Pediatric Emergency Department. Pediatrics. 2016 11; 138(5).
-
Van Iterson EH, Karpen SR, Baker SE, Wheatley CM, Morgan WJ, Snyder EM. Impaired cardiac and peripheral hemodynamic responses to inhaled ?2-agonist in cystic fibrosis. Respir Res. 2015 Sep 05; 16:103.
-
Wheatley CM, Baker SE, Morgan MA, Martinez MG, Liu B, Rowe SM, Morgan WJ, Wong EC, Karpen SR, Snyder EM. Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis. Respir Med. 2015 Aug; 109(8):1001-11.
-
Moodley T, Wilson SM, Joshi T, Rider CF, Sharma P, Yan D, Newton R, Giembycz MA. Phosphodiesterase 4 inhibitors augment the ability of formoterol to enhance glucocorticoid-dependent gene transcription in human airway epithelial cells: a novel mechanism for the clinical efficacy of roflumilast in severe chronic obstructive pulmonary disease. Mol Pharmacol. 2013 Apr; 83(4):894-906.
-
Bateman ED, Rabe KF, Calverley PM, Goehring UM, Brose M, Bredenbr?ker D, Fabbri LM. Roflumilast with long-acting ?2-agonists for COPD: influence of exacerbation history. Eur Respir J. 2011 Sep; 38(3):553-60.